Vitiligo epidemiology and demographics

Vitiligo Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Vitiligo from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Case Studies
Case #1
Vitiligo epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Vitiligo epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Vitiligo epidemiology and demographics
CDC on Vitiligo epidemiology and demographics
Vitiligo epidemiology and demographics in the news
Blogs on Vitiligo epidemiology and demographics
Directions to Hospitals Treating Vitiligo
Risk calculators and risk factors for Vitiligo epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Vitiligo is a worldwide spread disease that affects around 1% of the total world population. Both sexes are affected equally and a half of patients are diagnosed under the age of 20.

Epidemiology

Prevalence

• The overall prevalence of vitiligo is about 1% of the total worldwide population.
• This varies among geographical areas and age groups, from 0.1% up to more than 2%.

Age

• 50% of patients with vitiligo are diagnosed before the age of 20.

Gender

• There is no clear differences between gender, some studies report a higher incidence in women.Other mention that both sexes are equally affected by this disease.

• Female are diagnosed earlier than men.

Race

• There is no difference between races, but in dark skin patients it is more noticed and has a higher psychological impact.